Sirolimus-Eluting Coronary Stent System Tender - 146225429

Procurement Summary

State: West Bengal

Summary: Sirolimus-Eluting Coronary Stent System with Hybrid Coating -(Biolute and Probio) with Biodegradable Polymerplla having Strut Thickness of 60 Micron (Preferably Us Fda Approved). Stent Material - Coba...

Deadline: 17 Aug 2026

Posting Date: 30 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146225429

Document Ref. No.: 22265514

Financier: Self Financed

Purchaser Ownership: Public

Document Fees: Refer Document

Tender Value: Refer Document

EMD: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Sirolimus-Eluting Coronary Stent System with Hybrid Coating -(Biolute and proBio) with Biodegradable PolymerPLLA having strut thickness of 60 micron (preferably US FDA approved). Stent material - Cobalt Chromium, L-605. Passive coating - proBio (Amorphous Silicon Carbide). Active coating - BIOlute bioabsorbable Poly-L-Lactide (PLLA) eluting a limus drug. Size range from 2.25 to 4 mm. length 9 mm to 40 mm. Post-Expansion limit - 2.25 to 3 mm up to 3.5 mm. 3.5 to 4 mm up to 4.65 mm. Three years efficacy and safety of the stent in terms of Target Vessel Revascularisation (TVR) and In-Situ Thrombosis (IST) should be documented/published in peer reviewed scientific journals. The documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. Replacement warranty against any manufacturing defect noted on the O.T. table..[AI(2026-27), Item Code-No: S-62293, SL no.2192]

Sirolimus-Eluting Coronary Stent System with Hybrid Coating -(Biolute and proBio) with Biode gradable PolymerPLLA having strut thickness of 60 micron (preferably US FDA approved). Stent material - C obalt Chromium, L-605. Passive coating - proBio (Amorphous Silicon Carbide). Active coating - BIOlute bioab sorbable Poly-L-Lactide (PLLA) eluting a limus drug. Size range from 2.25 to 4 mm. length 9 mm to 40 mm. Post-Expansion limit - 2.25 to 3 mm up to 3.5 mm. 3.5 to 4 mm up to 4.65 mm. Three years efficacy and sa fety of the stent in terms of Target Vessel Revascularisation (TVR) and In-Situ Thrombosis (IST) should be d ocumented/published in peer reviewed scientific journals. The documents pertaining to the efficacy and saf ety of the stent should be enclosed for the brand that is offered in the tender bid. Replacement warranty ag ainst any manufacturing defect noted on the O.T. table..[AI(2026-27), Item Code-No: S-62293, SL no.2192] [ Warranty Period: 30 Months after the date of delivery ] ]

Contract Category: Expenditure
Contract Type : Goods

Tender Type : Limited - Indigenous

Contract Category : Expenditure

Evaluation Criteria : Itemwise/Consigneewise

Bidding System : Single Packet

Pre-Bid Conference Required : No

Pre-Bid Conference Date Time : Not Applicable

Tendering Section : 22

Inspection Agency : CONSIGNEE

Publishing Date / Time : 30/07/2026 11:38 Item Category General

Procure From Approved Sources : Yes

Approving Agency : My Zonal Approved Sources

Closing Date Time : 17/08/2026 13:30

Validity of Offer ( Days) : 90

Ranking Order for Bids : Lowest to Highest

Advertised Value :

Tender Doc. Cost (INR) : 0.00

Earnest Money (INR) : 0.00
Consignee MD/BRSH/SEALDAH, ER West Bengal 12.00 Numbers

Documents

 Tender Notice

viewNitPdf_5492462.pdf